Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	66	67	104	144	92	105
Market Cap Growth	41.73%	-35.77%	-27.72%	56.56%	-12.98%	121.15%
Enterprise Value	69	65	104	149	87	102
PE Ratio	-	-12.50	189.51	396.90	-43.85	823.96
PS Ratio	1.34	1.24	2.12	3.50	2.86	3.90
PB Ratio	-38.38	14.39	11.42	19.34	18.00	47.13
P/FCF Ratio	-11.75	60.64	25.25	-28.96	133.97	102.59
P/OCF Ratio	-15.75	16.79	15.98	-85.47	31.59	56.64
EV/Sales Ratio	1.41	1.21	2.12	3.62	2.72	3.78
EV/EBITDA Ratio	-10.73	-21.58	47.20	91.67	-76.65	122.16
EV/EBIT Ratio	-8.52	-12.38	178.92	340.02	-44.44	442.62
EV/FCF Ratio	-12.24	59.26	25.36	-29.95	127.34	99.46
Debt / Equity Ratio	-3.76	1.85	1.04	1.29	0.74	0.01
Debt / EBITDA Ratio	-1.01	-2.85	4.28	5.92	-3.34	0.02
Debt / FCF Ratio	-1.15	7.82	2.30	-1.93	5.54	0.02
Quick Ratio	0.56	0.83	1.06	1.04	1.07	0.95
Current Ratio	0.60	0.90	1.13	1.13	1.10	0.99
Asset Turnover	1.65	1.53	1.56	1.62	2.04	2.65
Return on Equity (ROE)	-850.70%	-71.50%	6.50%	5.20%	-69.10%	7.20%
Return on Assets (ROA)	-32.60%	-15.10%	1.70%	1.40%	-13.30%	1.30%
Return on Capital (ROIC)	-168.98%	-39.71%	3.07%	1.78%	-21.59%	6.64%
Earnings Yield	-14.72%	-8.00%	0.53%	0.25%	-2.28%	0.12%
FCF Yield	-10.17%	1.65%	3.96%	-3.45%	0.75%	0.97%
Buyback Yield / Dilution	-0.26%	4.37%	2.84%	-23.05%	15.98%	-28.25%
Total Shareholder Return	-0.26%	4.37%	2.84%	-23.05%	15.98%	-28.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).